Testing effectiveness (Phase 2)Study completedNCT01036087
What this trial is testing
Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer
Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 47
Showing 20 of 0 results